<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/D97BD78E-DF6B-4FC6-8F27-BF3A5DA3EDD8"><gtr:id>D97BD78E-DF6B-4FC6-8F27-BF3A5DA3EDD8</gtr:id><gtr:name>University of Ottawa</gtr:name><gtr:address><gtr:line1>550 Cumberland</gtr:line1><gtr:line4>Ottawa</gtr:line4><gtr:line5>Ontario K1N 6N5</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Canada</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/D6C3234E-5048-4AA0-A116-0CAC51569B2D"><gtr:id>D6C3234E-5048-4AA0-A116-0CAC51569B2D</gtr:id><gtr:name>University of Queensland</gtr:name><gtr:address><gtr:line1>University of Queensland</gtr:line1><gtr:line4>Brisbane</gtr:line4><gtr:line5>Queensland 4972</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Australia</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/8319F78A-DCBD-49F6-BE00-78E1CD75CDA9"><gtr:id>8319F78A-DCBD-49F6-BE00-78E1CD75CDA9</gtr:id><gtr:name>University of York</gtr:name><gtr:address><gtr:line1>Heslington</gtr:line1><gtr:line4>York</gtr:line4><gtr:line5>North Yorkshire</gtr:line5><gtr:postCode>YO10 5DD</gtr:postCode><gtr:region>Yorkshire and The Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/C842A34F-18F7-454D-A259-FED802368496"><gtr:id>C842A34F-18F7-454D-A259-FED802368496</gtr:id><gtr:name>University of Leicester</gtr:name><gtr:department>Health Sciences</gtr:department><gtr:address><gtr:line1>University Road</gtr:line1><gtr:line4>Leicester</gtr:line4><gtr:line5>Leicestershire</gtr:line5><gtr:postCode>LE1 7RH</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/C842A34F-18F7-454D-A259-FED802368496"><gtr:id>C842A34F-18F7-454D-A259-FED802368496</gtr:id><gtr:name>University of Leicester</gtr:name><gtr:address><gtr:line1>University Road</gtr:line1><gtr:line4>Leicester</gtr:line4><gtr:line5>Leicestershire</gtr:line5><gtr:postCode>LE1 7RH</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D97BD78E-DF6B-4FC6-8F27-BF3A5DA3EDD8"><gtr:id>D97BD78E-DF6B-4FC6-8F27-BF3A5DA3EDD8</gtr:id><gtr:name>University of Ottawa</gtr:name><gtr:address><gtr:line1>550 Cumberland</gtr:line1><gtr:line4>Ottawa</gtr:line4><gtr:line5>Ontario K1N 6N5</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Canada</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D6C3234E-5048-4AA0-A116-0CAC51569B2D"><gtr:id>D6C3234E-5048-4AA0-A116-0CAC51569B2D</gtr:id><gtr:name>University of Queensland</gtr:name><gtr:address><gtr:line1>University of Queensland</gtr:line1><gtr:line4>Brisbane</gtr:line4><gtr:line5>Queensland 4972</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Australia</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/8319F78A-DCBD-49F6-BE00-78E1CD75CDA9"><gtr:id>8319F78A-DCBD-49F6-BE00-78E1CD75CDA9</gtr:id><gtr:name>University of York</gtr:name><gtr:address><gtr:line1>Heslington</gtr:line1><gtr:line4>York</gtr:line4><gtr:line5>North Yorkshire</gtr:line5><gtr:postCode>YO10 5DD</gtr:postCode><gtr:region>Yorkshire and The Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/AB307619-D4FA-427E-A042-09DBEBA84669"><gtr:id>AB307619-D4FA-427E-A042-09DBEBA84669</gtr:id><gtr:name>Swansea University</gtr:name><gtr:address><gtr:line1>Singleton Park</gtr:line1><gtr:postCode>SA2 8PP</gtr:postCode><gtr:region>Wales</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/E59627CE-5A67-48D9-8D9D-3579BABF3518"><gtr:id>E59627CE-5A67-48D9-8D9D-3579BABF3518</gtr:id><gtr:firstName>Nicola</gtr:firstName><gtr:otherNames>J</gtr:otherNames><gtr:surname>Cooper</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G106%2F1170"><gtr:id>53E35EE2-9A68-42B0-ADC0-6D6B3E6D2A88</gtr:id><gtr:title>The use of evidence synthesis and uncertainty modelling in economic evidence-based health-related decision models</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Fellowship</gtr:grantCategory><gtr:grantReference>G106/1170</gtr:grantReference><gtr:abstractText>Resources dedicated to health care are limited and under increasing demand from consumers. It is therefore important that the resources available are used in order to produce the greatest benefit for the population. When clinical trial data is limited, decision modelling provides the best possible framework for performing cost-effectiveness analysis in which the additional costs of a new intervention are weighed against the additional effects. In particular it enables decision-makers to investigate the cost-effectiveness of a range of alternative treatment strategies for different settings or subgroups of patients. However, there are a number of methodological challenges associated with the practical application of decision modelling that need to be addressed. The aim of this project is to develop a more comprehensive decision modelling framework in which all available evidence can be incorporated into one coherent economic model and reported together with the appropriate measure(s) of uncertainty whilst making the overall results transparent and easy for the policy decision-maker to interpret.</gtr:abstractText><gtr:technicalSummary>Often economic and effectiveness data collected as part of a clinical trial are limited to short term outcomes and may not directly address the question of interest to decision-makers (e.g. a trial may compare active treatments to placebo rather than to each other). In these situations, decision modelling provides an ideal framework to investigate the cost-effectiveness of a range of alternative treatment strategies under different conditions, in different settings, populations and/or timeframes with the objective of generating valuable information to assist with the allocation of scarce health care resources efficiently and effectively, and for commissioning further research when appropriate. 

Health-related decision modelling is a developing subject area with numerous unresolved methodological and practical issues relating to the construction, evaluation and validation of such models and data inputs, which require further research. This project considers the interface between statistics and economic decision modelling and will draw on skills from a range of academic disciplines including decision/operational science, risk management, economics, epidemiology, mathematics and statistics. The main challenge of this project is to develop methods to enable all of the available evidence identified to be synthesised and incorporated into a health-related economic decision model whilst ensuring all uncertainty and correlation is accounted for appropriately. 

The project will consist of a systematic review of the literature to identify and appraise: (i) The use of systematic reviews (either directly or indirectly) to inform the structure and inputs of corresponding economic decision models to date and (ii) The methodology relevant to decision modelling across a range of academic disciplines not only healthcare. Drawing on the results of this review specific issues/problems associated with the application of economic decision modelling in a healthcare context will be addressed. For example, incorporation of all available evidence from a range of sources by applying evidence synthesis methods, and full allowance for all model parameter and structural uncertainty and correlations induced by the same sources of evidence propagating to different parts of a model. 

It is envisaged that this project will lead to the development of more rigorous decision modelling methods, which allow policy-makers concerned with health care evaluation to make more informed decisions, whilst improving the interpretability and transparency of the models and their results. With the creation of structures in the UK (NICE) and elsewhere to facilitate evidence-based health policy decision-making this is an area of global importance and advocates the need for a multidisciplinary approach.</gtr:technicalSummary><gtr:fund><gtr:end>2008-10-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2003-11-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>153003</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Ottawa</gtr:collaboratingOrganisation><gtr:country>Canada</gtr:country><gtr:description>Use of evidence in decision models</gtr:description><gtr:id>89D0BF2F-66B1-4020-B5A2-EB0590891D3F</gtr:id><gtr:impact>Coyle D, Lee K, Cooper NJ. Use of evidence in economic models. In I Shemilt, M Mugford, L Vale, K Marsh, C Donaldson. Evidence based economics: health and other policy domains. Blackwell Publishing Ltd PMID: 16259692</gtr:impact><gtr:outcomeId>87A1CBAAABF-1</gtr:outcomeId><gtr:partnerContribution>Wrote a book chapter together updating a previous version of the chapter written by the collaborator to include part of my MRC fellowship research. Also wrote a paper together on the use of evidence in decision models</gtr:partnerContribution><gtr:piContribution>See above</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Queensland</gtr:collaboratingOrganisation><gtr:country>Australia, Commonwealth of</gtr:country><gtr:description>Hospital-borne infections</gtr:description><gtr:id>877C206F-6469-4A5D-A5B7-94370BC49D36</gtr:id><gtr:impact>N Graves (PI), J Wilson (PI), K Mengersen, S Whitehouse, R Crawford, AJ Sutton, NJ Cooper, D Paterson, A Berendt. Using evidence to reduce risk of healthcare acquired infection following primary total hip replacement. NIHR Health Technology Assessment Programme (&amp;pound;305,000, Nov 2009 - Oct 2012)</gtr:impact><gtr:outcomeId>65A7B75C08C-1</gtr:outcomeId><gtr:piContribution>Advice about how to apply methods developed as part of my MRC fellowship to the area of Hospital-borne infections</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of York</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Centre for Health Economics (CHE)</gtr:department><gtr:description>Use of systematic review results in economic decision models</gtr:description><gtr:id>5BAB4DBD-8348-47AA-9ADA-9A6B36305842</gtr:id><gtr:impact>Paper: Drummond M, Iglesias C, Cooper NJ. Systematic reviews and economic evaluations in technology appraisals conducted for NICE in the UK: A game of two halves? International Journal of Technology Assessment in Health 2008; 24(2): 146-150.</gtr:impact><gtr:outcomeId>FC7C550B825-1</gtr:outcomeId><gtr:partnerContribution>Joint paper on use of Clinical review in economic decision models developed for NICE. Extended previous research undertaken as part of my fellowship</gtr:partnerContribution><gtr:piContribution>See above</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Taught courses for NICE and Pharmaceutical companies</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>2DAAE9B7-6EB0-4B81-9DF6-9040E28B582F</gtr:id><gtr:impact>Taught short courses to NICE technical team and TAR centres, and also pharmaceutical companies both in the UK and elsewhere

N/A</gtr:impact><gtr:outcomeId>E684E5ACE0D</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2006,2007,2008,2009</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>305000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Health Technology Assessment Programme (HTA)</gtr:department><gtr:description>NIHR Health Technology Assessment Programme</gtr:description><gtr:end>2012-10-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:id>C3882348-8B0A-4150-B84C-49D011B98937</gtr:id><gtr:outcomeId>E56DB9C204C0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2009-11-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>380000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Methodology Research Panel</gtr:description><gtr:end>2010-09-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>C4E8A928-46B8-4312-87D0-1989941292CD</gtr:id><gtr:outcomeId>11AFB8E7E290</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>2000000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>NIHR Programme Grant</gtr:description><gtr:end>2014-10-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:id>94583D8F-FDDB-40DA-8E30-B5EE07C050E9</gtr:id><gtr:outcomeId>F9B4E4436B70</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2009-04-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Evidence synthesis for decision making</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>02CDBF24-1154-4E9A-8142-394F6C87BB4E</gtr:id><gtr:impact>These courses showed how a more comprehensive approach to synthesis allows the evidence-base on clinical effectiveness to be treated as a coherent whole, include more data, and sometimes relax the assumptions currently made.</gtr:impact><gtr:outcomeId>63227C11926</gtr:outcomeId><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>98C93B9B-3BFF-4C11-8141-3652ACD8DDF0</gtr:id><gtr:title>Use of evidence in economic decision models: practical issues and methodological challenges.</gtr:title><gtr:parentPublicationTitle>Health economics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5980a4ac6bee6701a23bfdadb2397e8d"><gtr:id>5980a4ac6bee6701a23bfdadb2397e8d</gtr:id><gtr:otherNames>Cooper NJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1057-9230</gtr:issn><gtr:outcomeId>AB2BD665FE3</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DFAE724D-F964-4E55-9A3C-2C5EAF151B24</gtr:id><gtr:title>Pharmacological and lifestyle interventions to prevent or delay type 2 diabetes in people with impaired glucose tolerance: systematic review and meta-analysis.</gtr:title><gtr:parentPublicationTitle>BMJ (Clinical research ed.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1dfc559fcf89296a5fe4a0784ce7a97d"><gtr:id>1dfc559fcf89296a5fe4a0784ce7a97d</gtr:id><gtr:otherNames>Gillies CL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0959-535X</gtr:issn><gtr:outcomeId>EE828A12AFD</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>26320FE7-AEF4-45E7-8EC7-F795B39E4A12</gtr:id><gtr:title>Bayesian methods for evidence synthesis in cost-effectiveness analysis.</gtr:title><gtr:parentPublicationTitle>PharmacoEconomics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/be634fac835e6c6b3a8ab2f90cde0628"><gtr:id>be634fac835e6c6b3a8ab2f90cde0628</gtr:id><gtr:otherNames>Ades AE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1170-7690</gtr:issn><gtr:outcomeId>98CA885EABB</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F958CB10-96B3-473F-9302-A6671F325C25</gtr:id><gtr:title>Assessment of regression-based methods to adjust for publication bias through a comprehensive simulation study.</gtr:title><gtr:parentPublicationTitle>BMC medical research methodology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/37d6429f3ff43f894abfe659f6810568"><gtr:id>37d6429f3ff43f894abfe659f6810568</gtr:id><gtr:otherNames>Moreno SG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1471-2288</gtr:issn><gtr:outcomeId>277E46620BA</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3C2C8CB6-F2F2-42AE-85B3-B2693D7ECE57</gtr:id><gtr:title>Continuing the multiple sclerosis risk sharing scheme is unjustified.</gtr:title><gtr:parentPublicationTitle>BMJ (Clinical research ed.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4319dfcd8ef4be50b24fbceb03f6bfac"><gtr:id>4319dfcd8ef4be50b24fbceb03f6bfac</gtr:id><gtr:otherNames>McCabe C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0959-535X</gtr:issn><gtr:outcomeId>k1kBr1Cv1oC</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6E2C6BD1-D513-4E1A-B9CA-9AA18335F16A</gtr:id><gtr:title>Estimating the cost-effectiveness of an intervention in a clinical trial when partial cost information is available: a Bayesian approach.</gtr:title><gtr:parentPublicationTitle>Health economics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/911e4358932afc9a1c7ab191e7a89810"><gtr:id>911e4358932afc9a1c7ab191e7a89810</gtr:id><gtr:otherNames>Lambert PC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1057-9230</gtr:issn><gtr:outcomeId>DB8A66EFA16</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C8354FD4-2410-4895-B0C5-A77C50019259</gtr:id><gtr:title>Evidence-based sample size calculations based upon updated meta-analysis.</gtr:title><gtr:parentPublicationTitle>Statistics in medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/38c20e87272a134fc326e2c830c2b292"><gtr:id>38c20e87272a134fc326e2c830c2b292</gtr:id><gtr:otherNames>Sutton AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0277-6715</gtr:issn><gtr:outcomeId>37E59A1FBB3</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B4DA4ED9-0C5D-404A-A46B-6043480DCCEB</gtr:id><gtr:title>Addressing between-study heterogeneity and inconsistency in mixed treatment comparisons: Application to stroke prevention treatments in individuals with non-rheumatic atrial fibrillation.</gtr:title><gtr:parentPublicationTitle>Statistics in medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5980a4ac6bee6701a23bfdadb2397e8d"><gtr:id>5980a4ac6bee6701a23bfdadb2397e8d</gtr:id><gtr:otherNames>Cooper NJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0277-6715</gtr:issn><gtr:outcomeId>FC40C373DC1</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E2157CA7-8993-40B2-8328-DFDF14FECEDF</gtr:id><gtr:title>The Multiple Sclerosis Risk Sharing Scheme Monitoring Study--early results and lessons for the future.</gtr:title><gtr:parentPublicationTitle>BMC neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/239b3586d97a188dfcc81ec682bd843b"><gtr:id>239b3586d97a188dfcc81ec682bd843b</gtr:id><gtr:otherNames>Pickin M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1471-2377</gtr:issn><gtr:outcomeId>0C5E8CCC8C8</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5373588E-EF25-464A-B029-9CA6608939EF</gtr:id><gtr:title>Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial.</gtr:title><gtr:parentPublicationTitle>Lancet (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/388b645d40be134873fe952614c846d8"><gtr:id>388b645d40be134873fe952614c846d8</gtr:id><gtr:otherNames>Peek GJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0140-6736</gtr:issn><gtr:outcomeId>AA86A1B7D33</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1B0FF410-BC6F-49EC-BE2B-67080BCE1E5F</gtr:id><gtr:title>The clinical effectiveness and cost-effectiveness of enzyme replacement therapy for Gaucher's disease: a systematic review.</gtr:title><gtr:parentPublicationTitle>Health technology assessment (Winchester, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ea6904f11cf4b772e4e6fc6d0470fc36"><gtr:id>ea6904f11cf4b772e4e6fc6d0470fc36</gtr:id><gtr:otherNames>Connock M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1366-5278</gtr:issn><gtr:outcomeId>73A5B21E876</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A73D1764-5247-412C-A81E-29C9C26872C8</gtr:id><gtr:title>Integration of meta-analysis and economic decision modeling for evaluating diagnostic tests.</gtr:title><gtr:parentPublicationTitle>Medical decision making : an international journal of the Society for Medical Decision Making</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/38c20e87272a134fc326e2c830c2b292"><gtr:id>38c20e87272a134fc326e2c830c2b292</gtr:id><gtr:otherNames>Sutton AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0272-989X</gtr:issn><gtr:outcomeId>A50D6882CB7</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>833AD467-7E4C-4BCC-91B8-AD50C6C5CF44</gtr:id><gtr:title>The impact of diabetes on current revascularisation practice and clinical outcome in patients with critical lower limb ischaemia.</gtr:title><gtr:parentPublicationTitle>European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c649f17dcc17113d19fe220538ce95bd"><gtr:id>c649f17dcc17113d19fe220538ce95bd</gtr:id><gtr:otherNames>Awad S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1078-5884</gtr:issn><gtr:outcomeId>0B6E41E0F78</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C507D137-7B8E-47DB-A210-37E853460FAE</gtr:id><gtr:title>Evidence synthesis as the key to more coherent and efficient research.</gtr:title><gtr:parentPublicationTitle>BMC medical research methodology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/38c20e87272a134fc326e2c830c2b292"><gtr:id>38c20e87272a134fc326e2c830c2b292</gtr:id><gtr:otherNames>Sutton AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1471-2288</gtr:issn><gtr:outcomeId>37DC392FF54</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CEA708C3-B9EA-48EB-88FB-84D87EFCA7CF</gtr:id><gtr:title>The pro-inflammatory and chemotactic cytokine microenvironment of the abdominal aortic aneurysm wall: a protein array study.</gtr:title><gtr:parentPublicationTitle>Journal of vascular surgery</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/43191156b7315783c21b22a27404dc00"><gtr:id>43191156b7315783c21b22a27404dc00</gtr:id><gtr:otherNames>Middleton RK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0741-5214</gtr:issn><gtr:outcomeId>2A6F37165ED</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DCE3E847-45DC-4EC0-BE4D-D8D0A40AB10E</gtr:id><gtr:title>Novel methods to deal with publication biases: secondary analysis of antidepressant trials in the FDA trial registry database and related journal publications.</gtr:title><gtr:parentPublicationTitle>BMJ (Clinical research ed.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/37d6429f3ff43f894abfe659f6810568"><gtr:id>37d6429f3ff43f894abfe659f6810568</gtr:id><gtr:otherNames>Moreno SG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0959-535X</gtr:issn><gtr:outcomeId>150AD8E0226</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AAC671C5-EFA3-4FE7-95C5-4B7BD00860A9</gtr:id><gtr:title>Cost-effectiveness and value of information analyses of neuraminidase inhibitors for the treatment of influenza.</gtr:title><gtr:parentPublicationTitle>Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5d12618ed1f5067d9aa5aa82478991d5"><gtr:id>5d12618ed1f5067d9aa5aa82478991d5</gtr:id><gtr:otherNames>Wailoo AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1098-3015</gtr:issn><gtr:outcomeId>9E6F1EA8AA1</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EFA17330-BAE6-41E4-ABC2-B4A546A9076B</gtr:id><gtr:title>A systematic review of the clinical effectiveness and cost-effectiveness of enzyme replacement therapies for Fabry's disease and mucopolysaccharidosis type 1</gtr:title><gtr:parentPublicationTitle>HEALTH TECHNOLOGY ASSESSMENT</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ea6904f11cf4b772e4e6fc6d0470fc36"><gtr:id>ea6904f11cf4b772e4e6fc6d0470fc36</gtr:id><gtr:otherNames>Connock M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1366-5278</gtr:issn><gtr:outcomeId>5a3607c0a3b416.40925200</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CF5C0858-91F3-44A8-8875-3088BC435F99</gtr:id><gtr:title>Methods of data collection and analysis for the economic evaluation alongside a national, multi-centre trial in the UK: conventional ventilation or ECMO for Severe Adult Respiratory Failure (CESAR).</gtr:title><gtr:parentPublicationTitle>BMC health services research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/747dd52503fe0d63f5c30be2c510dd22"><gtr:id>747dd52503fe0d63f5c30be2c510dd22</gtr:id><gtr:otherNames>Thalanany MM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1472-6963</gtr:issn><gtr:outcomeId>CF40E4D5831</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1E957694-D9C4-4A7E-BED9-40429E16BF4C</gtr:id><gtr:title>Predicting costs over time using Bayesian Markov chain Monte Carlo methods: an application to early inflammatory polyarthritis.</gtr:title><gtr:parentPublicationTitle>Health economics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5980a4ac6bee6701a23bfdadb2397e8d"><gtr:id>5980a4ac6bee6701a23bfdadb2397e8d</gtr:id><gtr:otherNames>Cooper NJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1057-9230</gtr:issn><gtr:outcomeId>1A0F4487933</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8ABA226A-47F5-4D0E-8406-CDD6D1E18986</gtr:id><gtr:title>Use of indirect and mixed treatment comparisons for technology assessment.</gtr:title><gtr:parentPublicationTitle>PharmacoEconomics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5e16234f056b59eeefb02d76f0c702e0"><gtr:id>5e16234f056b59eeefb02d76f0c702e0</gtr:id><gtr:otherNames>Sutton A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1170-7690</gtr:issn><gtr:outcomeId>6B2B6DC7E8E</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B624E158-6C09-4371-95E5-975227A47AFA</gtr:id><gtr:title>Systematic reviews and economic evaluations conducted for the National Institute for Health and Clinical Excellence in the United Kingdom: a game of two halves?</gtr:title><gtr:parentPublicationTitle>International journal of technology assessment in health care</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8c288faa668790503620bba4622c27ee"><gtr:id>8c288faa668790503620bba4622c27ee</gtr:id><gtr:otherNames>Drummond MF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0266-4623</gtr:issn><gtr:outcomeId>2E386970A2F</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>68360909-F4B8-4194-B8F4-F2055F6A7612</gtr:id><gtr:title>Different strategies for screening and prevention of type 2 diabetes in adults: cost effectiveness analysis.</gtr:title><gtr:parentPublicationTitle>BMJ (Clinical research ed.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1dfc559fcf89296a5fe4a0784ce7a97d"><gtr:id>1dfc559fcf89296a5fe4a0784ce7a97d</gtr:id><gtr:otherNames>Gillies CL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0959-535X</gtr:issn><gtr:outcomeId>B19F47E61D5</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>11D905BD-E00C-4A2B-9A38-B817722724A8</gtr:id><gtr:title>The cost-effectiveness of influenza vaccination of healthy adults 50-64 years of age.</gtr:title><gtr:parentPublicationTitle>Vaccine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9f5401e07b1f28cc26f50d770bb42e18"><gtr:id>9f5401e07b1f28cc26f50d770bb42e18</gtr:id><gtr:otherNames>Turner DA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0264-410X</gtr:issn><gtr:outcomeId>6648BEB1AED</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4C7267E5-4391-41D3-B245-5CF1AB89C0E5</gtr:id><gtr:title>Mixed comparison of stroke prevention treatments in individuals with nonrheumatic atrial fibrillation.</gtr:title><gtr:parentPublicationTitle>Archives of internal medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5980a4ac6bee6701a23bfdadb2397e8d"><gtr:id>5980a4ac6bee6701a23bfdadb2397e8d</gtr:id><gtr:otherNames>Cooper NJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0003-9926</gtr:issn><gtr:outcomeId>2E00039FC2B</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9828B0B6-3858-4882-9022-360724113E8D</gtr:id><gtr:title>Meta-analysis of mixed treatment comparisons at multiple follow-up times.</gtr:title><gtr:parentPublicationTitle>Statistics in medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/708ada18da20f695ad331397095f2bf0"><gtr:id>708ada18da20f695ad331397095f2bf0</gtr:id><gtr:otherNames>Lu G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0277-6715</gtr:issn><gtr:outcomeId>991F74FD468</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9631AF0A-E22A-49EB-8E7A-C582E48C144E</gtr:id><gtr:title>Mixed treatment comparison with multiple outcomes reported inconsistently across trials: evaluation of antivirals for treatment of influenza A and B.</gtr:title><gtr:parentPublicationTitle>Statistics in medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d02be8b3f27b6d4932f6308c697cbd43"><gtr:id>d02be8b3f27b6d4932f6308c697cbd43</gtr:id><gtr:otherNames>Welton NJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0277-6715</gtr:issn><gtr:outcomeId>BB46AAFF870</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G106/1170</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>F3822669-BB5A-4BB4-BAE0-DCB9DE36E092</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Generic Health Relevance</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>237CBF0D-6B87-46FD-A97B-E432D87D3FE6</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>8.2  Health and welfare economics</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>